EMCDDA Home
  • EN
Search

Figure INF-6. HCV antibody prevalence among injecting drug users: studies with national and sub-national coverage

Part (iii) New injecting drug users (injecting less than 2 years), 2010–11

 
 
CountryyearNationalSub-national
Related links:
Sweden20100.0
Cyprus20110.0
Czech Republic20106.2
Hungary201110.520.012.17.116
Slovenia201115.4
Austria201118.511.1
United Kingdom2010/201119.720.3
Germany201118.530
Slovakia201026.1
Turkey201127.3
Portugal201040.0
Greece201152.539.522.241.90.075.060.020.022.230.020.050.060.750
Belgium201155.6
Finland
Poland
Romania
Bulgaria
Estonia
Ireland
Italy
Lithuania
Luxembourg
Malta
Netherlands
Croatia
Latvia
France
Norway
Denmark
Spain
http://www.emcdda.europa.eu/stats13/inffig6c.
For primary sources, study details and data before 2010, see INF-113 and INF-0
See also 'General notes for interpreting data' on the Explanatory notes and help page

Notes:

Black squares are samples with national coverage; blue triangles are samples with sub-national (including local or regional) coverage. Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary.

Countries are presented by order of increasing prevalence, based on the average of national data or, if not available, of sub-national data.

^Data are from England and Wales for 2011 and from Scotland (prevalence of 34.1) for 2010. 2011 data were collected from April 2011 to March 2012

Sources:

Reitox Network

CountrySwedenCyprusCzech RepublicHungarySloveniaAustriaUnited KingdomGermanySlovakiaTurkeyPortugalGreeceBelgium
National 0.06.210.515.418.5   27.340.052.5 
National           39.5 
Subnational0.0  20.0 11.119.718.526.1  22.255.6
Subnational   12.1  20.330   41.9 
Subnational   7.1       0.0 
Subnational   16       75.0 
Subnational           60.0 
Subnational           20.0 
Subnational           22.2 
Subnational           30.0 
Subnational           20.0 
Subnational           50.0 
Subnational           60.7 
Subnational           50 

inffig6c

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 12 March 2014